Affordable Access

Effect of spironolactone on blood pressure and the renin-angiotensin-aldosterone system in oligo-anuric hemodialysis patients.

Authors
Type
Published Article
Journal
American journal of kidney diseases : the official journal of the National Kidney Foundation
Publication Date
Volume
46
Issue
1
Pages
94–101
Identifiers
PMID: 15983962
Source
Medline

Abstract

When administered for 2 weeks, spironolactone, 50 mg twice daily, reduced predialysis systolic blood pressure, but did not produce hyperkalemia in oligo-anuric hemodialysis patients.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments
F